China criticizes U.S. for WHO pullout, accusing it of sidestepping international law
Stat News • 2/6/2026
Summary
China criticized the United States for its withdrawal from the World Health Organization (WHO). The criticism emphasized that countries should prioritize international law over domestic politics.
Advertisement
Lindy Score Breakdown (V4.2)
56d
Age
1
Sources
from cluster
1336
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1336/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1336/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 55 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
Biotech investors’ plea to Trump, and a busy M&A week
Stat News • Today
EPA to put microplastics on study list of contaminants in drinking water
Stat News • Today
Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk
Stat News • 1 day ago
Opinion: STAT+: Cardiology’s finally prioritizing prevention — but what will it look like?
Stat News • 1 day ago
STAT+: The biotech scorecard for the second quarter: 23 stock-moving events to watch
Stat News • 2 days ago
STAT reporter goes up against radiologists to spot deepfake X-rays
Stat News • 1 day ago
Opinion: Medical misinformation wins when patients can’t see their doctors
Stat News • 1 day ago
STAT+: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?
Stat News • 1 day ago
STAT+: The HSA industry makes its MAHA pitch
Stat News • 2 days ago
STAT+: NIH director’s invocation of Vannevar Bush’s legacy to promote Trump science policies sparks pushback
Stat News • 2 days ago
Anti-Lindy Similar stories
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 3 days ago